SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBaronsmead Vt Regulatory News (BVT)

Share Price Information for Baronsmead Vt (BVT)

Share Price is delayed by 15 minutes
Get Live Data
45.00    0.00 (0.00%)
Bid:
44.00
Ask:
46.00
Spread: 2.00 (4.545%)
Market Cap: £203.60m
BVT Live PriceLast checked at - London Stock Exchange

Intraday Baronsmead Vt Share Chart

Interim Management Statement

18 Feb 2010 15:12

Baronsmead VCT 2 plc

Interim management statement

For the three month period from 1 October 2009 to 31 December 2009

Financial Headlines

* 2.2% (1.9p per share) increase in underlying Net Asset Value (NAV) per share * 3.0p final dividend for the year ending 30 September 2009 paid on 30 December 2009 * 4.5% increase in the valuation of the unquoted portfolio largely as a result of improved trading within portfolio companies

Investment Objective and Dividend Policy

Baronsmead VCT 2 plc is a tax efficient listed company which aims to achieve long-term investment returns for private investors, including tax-free dividends.

The Board aims to sustain a minimum annual dividend level at an average of 5.5pper Ordinary Share, mindful of the need to maintain net asset value. Theability to meet these objectives depends significantly on the level and timingof profitable realisations and cannot be guaranteed. There will be variationsin the amount of dividends paid year on year. Since launch the average annualtax-free dividend paid to shareholders has been 6.2p per ordinary share(equivalent to a pre-tax return of 9.3p per ordinary share for a higher ratetaxpayer).Performance SummaryCapital return As at As at Movement 31 December 30 September % 2009 2009 Ordinary shares Total net assets £60.0m £61.2m Net asset value per 87.93p 86.06p* 2.2% share Share price 78.0p 77.5p 0.6% Premium/(Discount) to (11.3%) (13.0%) NAV *Adjusted for 3.0p final dividend for comparative purposes Total return 3 months to 1 year to 5 years to Ten years to 31 December 31 December 31 December 31 December 2009 2009 2009 2009 Ordinary shares Net asset value 1 2.1% 7.6% 20.4% 48.6% Share price2 2.5% 7.8% 23.0% 59.7% FTSE All-share3 5.5% 30.1% 36.8% 17.7%

1 NAV Total return = NAV + reinvested dividends; Source: ISIS EP LLP

2 Share price Total return = mid to mid share price + reinvested dividends; Source: AIC

3 FTSE All-share = FTSE All-share Index + reinvested dividends; Source: AIC

InvestmentPerformance

Both the AIM and unquoted portfolios increased in value over the quarter. After accounting for these gains and the payment of the 3.0p final dividend, paid 30 December 2009, the NAV per share at 31 December 2009 was 87.93p. This equates to an underlying quarterly increase of 2.2%.

Investment Activity

During the period ScriptSwitch, an unquoted investment made in May 2007, was realised resulting in a return, including expected future payments, approaching four times the initial cost.

Five AIM traded investments totalling £0.8m were completed in two existingportfolio companies and two new companies. Baronsmead VCT 2 also receivedshares in Chime Communications plc when that company acquired Essentially GroupLtd.Investments made Date Cost (£'000) Adventis Group plc Dec 09 81 Electric Word plc Nov 09 36 Green Compliance plc (new) Dec 09 250 Chime Communications plc (takeover Essentially Group Nov 09 369Ltd) Marwyn Value Investors plc (new) Nov 09 64 Total Investments 800In total three AIM investments were realised in full and another, Ffastfillplc, part sold.Realisations Company Date Cost Proceeds (£ Multiple '000) (£'000) Essentially Group Ltd Nov 09 495 369 0.7 (Acquired by Chime Communications plc see above) Ffastfill plc Dec 09 226 359 1.6 Research Now plc Dec 09 263 376 1.4 Silverdell plc Dec 09 14 1 0.1 Total realisations 998 1,105 1.1

In addition three AIM investments were written off, MKM Group plc, Optimisa plc and Relax Group plc.

Top ten investment holdings

Position as at Position as Company Percentage of at net assets as at 31 December 31 December 2009 30 September 2009 2009 1 1 Reed and Mackay 5.2 2 4 Carnell Contractors 4.4 3 3 Nexus Vehicle 4.2 4 6 Quantix 3.1 5 5 Cablecom 3.1 6 8 Fisher Outdoor 3.0 7 7 ILS 2.6 8 9 Kaf©vend 2.4 9 10 Crew Clothing 2.2 10 11 CSC 2.1 Total 32.3Sector breakdown

(excluding cash and interest bearing securities)

Percentage of total Percentage of total investments at investments at 31 December 2009 30 September 2009 Business Services 38 35 Consumer Markets 13 12 IT & Media 31 28 Healthcare & Education 12 19 Financial Services 6 6 Total 100 100

12th Annual General Meeting on 14 December 2009

The AGM was attended by over 100 Shareholders and included a number of presentations and a shareholder workshop. The Chairman gave his view on the current economic situation followed by comment on the investment environment from the Manager. Colin MacAdam, Managing Director of Playforce, presented the growth story of this business.

Events since 31 December 2009

Other than as disclosed in this statement the Board is not aware of any significant events or transactions which have occurred between 31 December 2009 and the date of publication of this statement which would have a material impact on the financial position of the Company.

The NAV per share at 31 January 2010 was 88.02p.

Further information

Information regarding the Company, including latest financial statements or quarterly factsheets, can be found at the Company's website www.baronsmeadvct2.co.uk.

For further information please contact:

Michael Probin, VCT Investor Relations, ISIS EP LLP on 020 7506 5796 or michael.probin@isisep.com.

Barry Lawson, Company Secretary, on 020 7506 5658 or barry.lawson@isisep.com.

vendor
Date   Source Headline
6th Sep 20225:45 pmRNSNet Asset Value(s)
1st Sep 20225:52 pmRNSTotal Voting Rights
16th Aug 20224:49 pmRNSTransaction in Own Shares
12th Aug 202211:44 amRNSIntention to Fundraise
4th Aug 20226:00 pmRNSNet Asset Value(s)
20th Jul 20227:00 amRNSNet Asset Value(s)
1st Jul 20224:46 pmRNSTotal Voting Rights
15th Jun 20227:00 amRNSTransaction in Own Shares
8th Jun 20223:15 pmRNSNet Asset Value(s)
27th May 20227:00 amRNSHalf-year Report
6th May 20223:15 pmRNSNet Asset Value(s)
3rd May 20223:09 pmRNSTotal Voting Rights
25th Apr 20226:03 pmRNSTransaction in Own Shares
14th Apr 20223:00 pmRNSNet Asset Value(s)
1st Apr 20227:00 amRNSTotal Voting Rights
15th Mar 20224:30 pmRNSIssue of Equity
11th Mar 20223:00 pmRNSNet Asset Value(s)
9th Mar 20227:00 amRNSTransaction in Own Shares - Correction
8th Mar 20223:32 pmRNSTransaction in Own Shares
7th Mar 20223:30 pmRNSPublication of a Prospectus
3rd Mar 20221:30 pmRNSNet Asset Value(s)
1st Mar 202211:42 amRNSTotal Voting Rights
28th Feb 20225:00 pmRNSOffer for Subscription - Update
16th Feb 20224:58 pmRNSResult of AGM
15th Feb 20225:41 pmRNSDirectorate Change
15th Feb 20223:26 pmRNSOffer for Subscription - Update
4th Feb 20225:45 pmRNSNet Asset Value(s)
3rd Feb 20224:58 pmRNSTotal Voting Rights
1st Feb 20222:53 pmRNSTotal Voting Rights
28th Jan 202212:00 pmRNSAllotment of Shares
27th Jan 20223:30 pmRNSNet Asset Value(s)
26th Jan 20225:00 pmRNSTransaction in Own Shares
21st Jan 20222:00 pmRNSNet Asset Value(s)
4th Jan 20221:34 pmRNSTotal Voting Rights
23rd Dec 20211:18 pmRNSDirector/PDMR Shareholding
22nd Dec 20214:52 pmRNSAllotment of Shares
20th Dec 20216:06 pmRNSTransaction in Own Shares
20th Dec 202112:37 pmRNSUpdate on Fundraising
8th Dec 202111:48 amRNSDirector/PDMR Shareholding
8th Dec 202111:46 amRNSDirector/PDMR Shareholding
8th Dec 202111:25 amRNSDirector/PDMR Shareholding
7th Dec 20213:52 pmRNSPublication of a supplementary prospectus
6th Dec 20215:20 pmRNSAllotment of Shares
6th Dec 20212:26 pmRNSAnnual Financial Report
3rd Dec 20214:00 pmRNSNet Asset Value(s)
10th Nov 20218:00 amRNSOffer update – Extension of Earlybird Rebate
8th Nov 20215:45 pmRNSNet Asset Value(s)
4th Nov 202112:34 pmRNSPublication of a Prospectus
28th Oct 20213:00 pmRNSReplacement Net Asset Value(s)
21st Oct 20211:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.